Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)
Clinical trial NCT06696443 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06696443
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2027-01-25
- Enrollment
- 455
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.